STAT3 and Hepatic fibrosis: To further verify the therapeutic effect of Ssb1 on liver fibrosis by STAT3 inhibition, we utilized a thioacetamide (TAA)‐induced liver fibrosis model to estimate the antifibrosis effect of Ssb1.